HOME >> MEDICINE >> NEWS
UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded a UCLA research team a five-year, $9 million contract to fund a multicenter study investigating antibiotic treatments for MRSA, a staph infection seen increasingly in communities across the nation that is resistant to antibiotics most commonly used to treat skin infections.

The study, to be led by co-principal investigators Dr. David A. Talan and Dr. Gregory J. Moran, both of Olive ViewUCLA Medical Center and the David Geffen School of Medicine at UCLA, will explore whether various off-patent antibiotics for the treatment of uncomplicated skin and soft tissue infections may be effective in treating MRSA, or methicillin-resistant Staphylococcus aureus. Off-patent medications are those whose patents have expired, allowing any manufacturer to produce them.

The emergence of the new, potentially more infectious and virulent strain of S. aureus in the community, referred to as community-associated or CAMRSA, has caused serious outbreaks of disease over the past few years, said Talan, a professor of medicine at the Geffen School of Medicine and chief of emergency medicine and professor of infectious diseases at Olive ViewUCLA. We are hopeful to be able to identify the most effective antibiotic treatment for these infections.

Last year, the research team reported in The New England Journal of Medicine that CA-MRSA had become the most common cause of skin and soft tissue infections among patients presenting to a geographically diverse group of 11 emergency departments across the nation. Researchers tested MRSA resistance to antibiotics in a test tube and found that in 57 percent of cases, doctors had prescribed an antibiotic to which the bacteria were resistant. Finding certain antibiotics ineffective against MRSA in a laboratory setting, however, does not necessarily mean they will fail in patients, who have the help of thei
'"/>

Contact: Rachel Champeau
rchampeau@mednet.ucla.edu
310-794-0777
University of California - Los Angeles
9-Aug-2007


Page: 1 2

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. Penn researchers discover novel pathway for increasing good cholesterol
3. Theory of facial aging gets a facelift from UT Southwestern researchers
4. UIC researchers to develop new drugs to fight bioterrorism
5. UQ researchers discover some of the oldest forms of life
6. U of M researchers discover new method to combat HIV
7. U of M researchers assess effectiveness of computerized physician order entry system
8. Nepalese researchers identify cost-effective treatment for drug-resistant typhoid
9. Physician-researchers often less successful in obtaining NIH funding
10. UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells
11. Cedars-Sinai researchers present new endocrine findings at 2 international conferences

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... Pa. (PRWEB) , ... October 13, 2017 , ... While ... dark poses a problem. Fortunately, an inventor from Austin, Texas, has identified a solution. ... to medication in darkness or restricted lighting. As such, it eliminates the need to ...
(Date:10/13/2017)... ... 2017 , ... PurhealthRX , a leading Health and Nutrition Company, is ... to full spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing ... easily incorporated into liquid products, while reducing costs to end users. , The team ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes ... a mock evacuation of the facility as part of a disaster drill on October ... Hose EMS and Shelton City Emergency Manager, as well as the Connecticut Long ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... be giving viewers the lowdown on sciatica in a new episode of "Success ... focuses on current events and innovation and investigates each subject in-depth with passion ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: ... that developed an innovative way to use nonlinear optical ... delivery of new drugs. ... Dermatology Conference will show how researchers from BioPharmX and ... Medical School used a suite of imaging techniques in ...
(Date:10/10/2017)... Pa. , Oct. 10, 2017   West ... in innovative solutions for injectable drug administration, today shared ... West,s ID Adapter for improving the intradermal administration of ... Fourth Skin Vaccination Summit in May 2017 by Dr. ... Lead, Polio Department, World Health Organization (WHO), and recently ...
(Date:10/4/2017)... , Oct. 4, 2017 ... single-use, self-contained, illuminating medical devices, today announced regulatory ... Health Surveillance Agency (or Agência Nacional de Vigilância ... first single-use, cordless surgical retractor with integrated LED ... optimal access, illumination and exposure of a tissue ...
Breaking Medicine Technology:
Cached News: